ESSA Pharma Performance

ESSA Pharma Relative Risk vs. Return Landscape

If you would invest  20.00  in ESSA Pharma on November 15, 2025 and sell it today you would earn a total of  0.00  from holding ESSA Pharma or generate 0.0% return on investment over 90 days. ESSA Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ESSA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.

ESSA Pharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.25 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ESSA Pharma will likely underperform. Additionally ESSA Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for ESSA Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ESSA Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.20 0.20 0.20 Details

Intrinsic Valuation Low Real High 0.19 0.19 0.22 Details

ESSA Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ESSA Pharma is not an exception. The market had few large corrections towards the ESSA Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ESSA Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ESSA Pharma within the framework of very fundamental risk indicators.

ESSA Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ESSA Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ESSA Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

ESSA Pharma Price Density Drivers

ESSA Pharma Fundamentals Growth

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.